These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 31001537)

  • 1. Protein Misfolding and ER Stress in Huntington's Disease.
    Shacham T; Sharma N; Lederkremer GZ
    Front Mol Biosci; 2019; 6():20. PubMed ID: 31001537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoplasmic reticulum stress: The cause and solution to Huntington's disease?
    Jiang Y; Chadwick SR; Lajoie P
    Brain Res; 2016 Oct; 1648(Pt B):650-657. PubMed ID: 27040914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein aggregation and ER stress.
    Ogen-Shtern N; Ben David T; Lederkremer GZ
    Brain Res; 2016 Oct; 1648(Pt B):658-666. PubMed ID: 27037184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Converging pathways in the occurrence of endoplasmic reticulum (ER) stress in Huntington's disease.
    Vidal R; Caballero B; Couve A; Hetz C
    Curr Mol Med; 2011 Feb; 11(1):1-12. PubMed ID: 21189122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular stress responses in protein misfolding diseases.
    Duennwald ML
    Future Sci OA; 2015 Sep; 1(2):FSO42. PubMed ID: 28031871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small molecule modulator of protein disulfide isomerase attenuates mutant huntingtin toxicity and inhibits endoplasmic reticulum stress in a mouse model of Huntington's disease.
    Zhou X; Li G; Kaplan A; Gaschler MM; Zhang X; Hou Z; Jiang M; Zott R; Cremers S; Stockwell BR; Duan W
    Hum Mol Genet; 2018 May; 27(9):1545-1555. PubMed ID: 29462355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleic Acid Therapeutics in Huntington's Disease.
    Singh K; Roy I
    Recent Pat Biotechnol; 2019; 13(3):187-206. PubMed ID: 30747088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Green tea (-)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models.
    Ehrnhoefer DE; Duennwald M; Markovic P; Wacker JL; Engemann S; Roark M; Legleiter J; Marsh JL; Thompson LM; Lindquist S; Muchowski PJ; Wanker EE
    Hum Mol Genet; 2006 Sep; 15(18):2743-51. PubMed ID: 16893904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional profiles for distinct aggregation states of mutant Huntingtin exon 1 protein unmask new Huntington's disease pathways.
    Moily NS; Ormsby AR; Stojilovic A; Ramdzan YM; Diesch J; Hannan RD; Zajac MS; Hannan AJ; Oshlack A; Hatters DM
    Mol Cell Neurosci; 2017 Sep; 83():103-112. PubMed ID: 28743452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The stress rheostat: an interplay between the unfolded protein response (UPR) and autophagy in neurodegeneration.
    Matus S; Lisbona F; Torres M; León C; Thielen P; Hetz C
    Curr Mol Med; 2008 May; 8(3):157-72. PubMed ID: 18473817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review on protein misfolding, aggregation and strategies to prevent related ailments.
    Shamsi TN; Athar T; Parveen R; Fatima S
    Int J Biol Macromol; 2017 Dec; 105(Pt 1):993-1000. PubMed ID: 28743576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IRE1 plays an essential role in ER stress-mediated aggregation of mutant huntingtin via the inhibition of autophagy flux.
    Lee H; Noh JY; Oh Y; Kim Y; Chang JW; Chung CW; Lee ST; Kim M; Ryu H; Jung YK
    Hum Mol Genet; 2012 Jan; 21(1):101-14. PubMed ID: 21954231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AAV-mediated delivery of the transcription factor XBP1s into the striatum reduces mutant Huntingtin aggregation in a mouse model of Huntington's disease.
    Zuleta A; Vidal RL; Armentano D; Parsons G; Hetz C
    Biochem Biophys Res Commun; 2012 Apr; 420(3):558-63. PubMed ID: 22445760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic Advances for Huntington's Disease.
    Kumar A; Kumar V; Singh K; Kumar S; Kim YS; Lee YM; Kim JJ
    Brain Sci; 2020 Jan; 10(1):. PubMed ID: 31940909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The P42 peptide and Peptide-based therapies for Huntington's disease.
    Marelli C; Maschat F
    Orphanet J Rare Dis; 2016 Mar; 11():24. PubMed ID: 26984770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signaling Overlap between the Golgi Stress Response and Cysteine Metabolism in Huntington's Disease.
    Paul BD
    Antioxidants (Basel); 2021 Sep; 10(9):. PubMed ID: 34573100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein Misfolding and Aggregation as a Therapeutic Target for Polyglutamine Diseases.
    Takeuchi T; Nagai Y
    Brain Sci; 2017 Oct; 7(10):. PubMed ID: 29019918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The unfolded protein response and its potential role in Huntington's disease elucidated by a systems biology approach.
    Kalathur RK; Giner-Lamia J; Machado S; Barata T; Ayasolla KR; Futschik ME
    F1000Res; 2015; 4():103. PubMed ID: 26949515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Unfolded Protein Response and the Role of Protein Disulfide Isomerase in Neurodegeneration.
    Perri ER; Thomas CJ; Parakh S; Spencer DM; Atkin JD
    Front Cell Dev Biol; 2015; 3():80. PubMed ID: 26779479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herp Promotes Degradation of Mutant Huntingtin: Involvement of the Proteasome and Molecular Chaperones.
    Luo H; Cao L; Liang X; Du A; Peng T; Li H
    Mol Neurobiol; 2018 Oct; 55(10):7652-7668. PubMed ID: 29430620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.